OTCMKTS:TRUMY - Terumo Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$44.40
▲ +0.63 (1.44%)

This chart shows the closing price for TRUMY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Terumo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRUMY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRUMY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Terumo in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $44.40.

This chart shows the closing price for TRUMY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Terumo.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/14/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral
7/22/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 10/23/2016 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
8/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/23/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/23/2021

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

Terumo logo
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Read More

Today's Range

Now: $44.40
Low: $44.34
High: $44.61

50 Day Range

MA: $44.86
Low: $39.08
High: $50.52

52 Week Range

Now: $44.40
Low: $34.25
High: $50.53

Volume

9,064 shs

Average Volume

22,064 shs

Market Capitalization

$33.72 billion

P/E Ratio

39.29

Dividend Yield

0.42%

Beta

0.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Terumo?

The following Wall Street analysts have issued stock ratings on Terumo in the last twelve months: Credit Suisse Group AG, and Zacks Investment Research.
View the latest analyst ratings for TRUMY.

What is the current price target for Terumo?

0 Wall Street analysts have set twelve-month price targets for Terumo in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Terumo in the next year.
View the latest price targets for TRUMY.

What is the current consensus analyst rating for Terumo?

Terumo currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TRUMY, but not buy more shares or sell existing shares.
View the latest ratings for TRUMY.

What other companies compete with Terumo?

Other companies that are similar to Terumo include Henry Schein, Patterson Companies, Owens & Minor, Fuse Medical, BrewBilt Manufacturing and InternetArray.

How do I contact Terumo's investor relations team?

Terumo's physical mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The company's listed phone number is (133) 374-8111 and its investor relations email address is [email protected] The official website for Terumo is www.terumo.co.jp.